Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.
A Phase 3 trial of Rituxan (rituximab) as a maintenance therapy in adults with mantle cell lymphoma after a stem cell transplant found that the treatment improved survival rates over four ... Read more
A gene therapy-based cancer treatment completely eliminated traces of tumor cells in 40 percent of patients with certain B-cell malignancies, according to data from a Phase 1/2a clinical trial. The ... Read more
Using radioactive iodine as a follow-up treatment to thyroid cancer surgery increases the risk of a patient developing acute myeloid leukemia and having a poorer outcome, a study reports. Researchers presented ... Read more
The U.S. Food and Drug Administration is advising healthcare professionals and patients not to use liquid products manufactured by PharmaTech because they may be contaminated with a bacteria that can ... Read more
The antibody-based synthetic therapy STRO-001 killed cancerous B-cells in the blood of mice with multiple myeloma, and the animals remained tumor-free the entire four-month test period, according to a ... Read more
People successfully treated for Hodgkin’s lymphoma (HL) are more likely to develop a second cancer if they have a close relative with that type of cancer. The most common ... Read more
Pin It on Pinterest